Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant FEC100/Cisplatin-Docetaxel ± Trastuzumab in HER2+ LABC
NCT00535509Phase 2Completed
- Sponsor
- King Faisal Specialist Hospital and Research Centre
- Start
- Jun 2007
- Primary completion
- Jun 2013
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of trastuzumab in breast cancer, sponsored by King Faisal Specialist Hospital and Research Centre. Started Jun 2007; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00535509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00535509.